Hepatocytes produce tumor necrosis factor-α and interleukin-6 in response to Porphyromonas gingivalis

Journal of Periodontal Research

Volumn 47, Issue 1, 2012, Pages 89-94

  Takano, M ^a   Sugano, N ^a   Mochizuki, S ^a   Koshi, R N ^a   Narukawa, T S ^a   Sawamoto, Y ^a   Ito, K ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Anti TNF IgG; Diabetes mellitus; Interleukin 6; Porphyromonas gingivalis; Tumor necrosis factor

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL LINE; COCULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LIVER CELL; MACROPHAGE; MICROBIOLOGICAL EXAMINATION; MOUSE; PORPHYROMONAS GINGIVALIS; REAL TIME POLYMERASE CHAIN REACTION; TIME; TUMOR CELL LINE;

ANIMALS; ANTIBODIES; BACTERIOLOGICAL TECHNIQUES; CELL LINE; CELL LINE, TUMOR; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATOCYTES; IMMUNOGLOBULIN G; INTERLEUKIN-6; MACROPHAGES; MICE; PORPHYROMONAS GINGIVALIS; REAL-TIME POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855351057     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01408.x     Document Type: Article

References (43)

1. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144.
2. Tanner A, Kent R, Maiden MF, Taubman MA. Clinical, microbiological and immunological profile of healthy, gingivitis and putative active periodontal subjects. J Periodontal Res 1996;31:195-204.
3. Katz PP, Wirthlin MR Jr, Szpunar SM, Selby JV, Sepe SJ, Showstack JA. Epidemiology and prevention of periodontal disease in individuals with diabetes. Diabetes Care 1991;14:375-385.
4. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991;62:123-131.
5. Grossi SG, Zambon JJ, Ho AW et al. Assessment of risk for periodontal disease I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
6. Hugoson A, Thorstensson H, Falk H, Kuylenstierna J. Periodontal conditions in insulin-dependent diabetics. J Clin Periodontol 1989;16:215-223.
7. Nelson RG, Shlossman M, Budding LM et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990;13:836-840.
8. Oliver RC, Tervonen T. Periodontitis and tooth loss: comparing diabetics with the general population. J Am Dent Assoc 1993;124:71-76.
9. Papapanou PN. Periodontal diseases: epidemiology. Ann Periodontol 1996;1:1-36.
10. Argilés JM, López-Soriano J, López-Soriano FJ. Cytokines and diabetes: the final step? Involvement of TNF-alpha in both type I and II diabetes mellitus Horm Metab Res 1994;26:447-449.
11. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res Clin Pract 2001;52:119-123.
12. Fernandez-Real JM, Lainez B, Vendrell J et al. Shedding of TNF-α receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002;282:E952-E959.
13. Lechleitner M, Herold M, Dzien-Bischinger C, Hoppichler F, Dzien A. Tumour necrosis factor-α plasma levels in elderly patients with type 2 diabetes mellitus-observations over 2years. Diabet Med 2002;19:949-953.
14. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992;130:43-52.
15. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesityinduced insulin resistance. Science 1996;271:665-668.
16. Kroder G, Bossenmaier B, Kellerer M et al. Tumor necrosis factor-alpha - and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 1996;97:1471-1477.
17. Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α. Effect of weight loss in obese men. Eur J Endocrinol 2003;148:535-542.
18. Krady JK, Basu A, Allen CM et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005;54:1559-1565.
19. Siragy HM, Awad A, Abadir P, Webb R. The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats. Endocrinology 2003;144:2229-2233.
20. Satoh J, Yagihashi S, Toyota T. The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Exp Diabesity Res 2003;4:65-71.
21. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. J Periodontol 2003;74:97-102.
22. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003;24:278-301.
23. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 1998;50:515-596.
24. Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995;152:76-80.
25. Laskin DL. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis 1990;10:293-304.
26. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006;26:1175-1186.
27. Parker GA, Picut CA. Liver immunobiology. Toxicol Pathol 2005;33:52-62.
28. Nishihara R, Sugano N, Takano M et al. The effect of Porphyromonas gingivalis infection on cytokine levels in type 2 diabetic mice. J Periodontal Res 2009;44:305-310.
29. Takano M, Nishihara R, Sugano N et al. The effect of systemic anti-tumor necrosis factor-alpha treatment on Porphyromonas gingivalis infection in type 2 diabetic mice. Arch Oral Biol 2010;55:379-384.
30. Curran RD, Billiar TR, Stuehr DJ, Hofmann K, Simmons RL. Hepatocytes produce nitrogen oxides from l-Arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989;170:1769-1774.
31. Tanoue T, Nishitani Y, Kanazawa K, Hashimoto T, Mizuno M. In vitro model to estimate gut inflammation using co-cultured Caco-2 and RAW264.7 cells. Biochem Biophys Res Commun 2008;26:565-569.
32. Shimada T, Sugano N, Nishihara R, Suzuki K, Tanaka H, Ito K. Differential effects of five Aggregatibacter actinomycetemcomitans strains on gingival epithelial cells. Oral Microbiol Immunol 2008;23:455-458.
33. Benacerraf B, Sebestyen MM, Schlossman S. A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and staphylococci by the reticuloendothelial system. J Exp Med 1959;110:27-48.
34. North RJ. T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis. Infect Immun 1974;10:66-71.
35. Gregory SH, Sagnimeni AJ, Wing EJ. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J Immunol 1996;157:2514-2520.
36. Gregory SH, Cousens LP, van Rooijen N, Döpp EA, Carlos TM, Wing EJ. Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver. J Immunol 2002;168:308-315.
37. Fox ES, Thomas P, Broitman SA. Comparative studies of endotoxin uptake by isolated rat Kupffer and peritoneal cells. Infect Immun 1987;55:2962-2966.
38. Jacob AI, Goldberg PK, Bloom N, Degenshein GA, Kozinn PJ. Endotoxin and bacteria in portal blood. Gastroenterology 1977;72:1268-1270.
39. Darlington GJ, Wilson DR, Lachman B. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol 1986;103:787-793.
40. Callery PM, Kamei T, Flye MW. Endotoxin stimulates interleukin-6 production by human Kupffer cells. Circ Shock 1992;37:185-188.
41. Curran RD, Billiar TR, Stuehr DJ et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 1990;212:462-471.
42. Hunt JS, Chen HL, Hu XL, Chen TY, Morrison DC. Tumor necrosis factor-alpha gene expression in the tissues of normal mice. Cytokine 1992;4:340-346.
43. Panesar N, Tolman K, Mazuski JE. Endotoxin stimulates hepatocyte interleukin-6 production. J Surg Res 1999;85:251-258.